In obesity, the endogenous endocannabinoid anandamide (AEA) promotes appetite and reduces energy expenditure through the activation of cannabinoid receptor 1 (CB1) (4). Here, CNR1 is linked to obesity due to melanocortin 4 receptor deficiency.